We were also able to confirm that the carrier frequency of NPHP1 heterozygous deletions was 0.35% within a non-rare-disease cohort (the GE100kGP cancer cohort) and 0.54% within the 1000 Genomes project. The gene discussed is NPHP1; the disease is cancer.